Document is current
Any future updates will be listed below
-
Authors
Cinar, Irfan https://orcid.org/0000-0002-9826-2556
Sirin, Busra https://orcid.org/0000-0001-8519-1747
Halici, Zekai https://orcid.org/0000-0001-6854-6059
Palabiyik-Yucelik, Saziye Sezin https://orcid.org/0000-0002-6239-6114
Akpinar, Erol https://orcid.org/0000-0003-1428-6807
Cadirci, Elif https://orcid.org/0000-0003-0836-7205
-
Funding
Funding for this research was provided by:
Türkiye Bilimsel ve Teknolojik Araştirma Kurumu (214S006)
- License Information
-
More Information
Article History
Received: 11 August 2020
Accepted: 11 January 2021
First Online: 2 February 2021
Compliance with ethical standards
:
: Author IC declares that he has no conflict of interest. Author BS declares that she has no conflict of interest. Author ZH declares that he has no conflict of interest. Author SSPY declares that she has no conflict of interest. Author EA declares that he has no conflict of interest. Author EC declares that she has no conflict of interest. Part of the study “6 with international participation. Drug chemistry: design, synthesis, production and standardization of drug active substance presented orally at the Congress.”
: For the use of human samples from pathology archive, this study was approved by the local ethics committee of Ataturk University (B.30.2.ATA.0.01.00/82 and 2016/4/36).
: For this type of study, formal consent is not required
